Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Serlopitant for Pruritus in Atopic Dermatitis
NCT02975206Phase 2Completed
- Sponsor
- Vyne Therapeutics
- Start
- Nov 2016
- Primary completion
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of serlopitant in atopic dermatitis (AD) (3 arms), sponsored by Vyne Therapeutics. Primary endpoint: Change in Worst Itch Numeric Rating Scale From Baseline to Week 6. Started Nov 2016; status: completed.
02
Drugs
serlopitant
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT02975206.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02975206.